Iconic Labs PLC Result of AGM

RNS Number : 0017D

Iconic Labs PLC

13 February 2024

Iconic Labs PLC

("Iconic" or the "Company")

Result of AGM

Iconic Labs PLC (LSE: ICON) is pleased to announce that at the Company's Annual General Meeting ('AGM') held earlier today, Resolutions 1 to 10 were all duly approved by shareholders by way of a poll.

At the meeting, inter alia, a resolution was passed which approved the sub-division and conversion of each existing ordinary share of £0.10 ("Existing Ordinary Shares") into one new ordinary share of £0.0001 (a "New Ordinary Share") and one deferred share of £0.0999 (a "Deferred Share") (each such Deferred Share having no voting or dividend rights and effectively being worthless) in order that the nominal value of a New Ordinary Share is less than the price of a share in the market.

As a result, the Company's issued share capital will consist of 11,161,483 ordinary shares of £0.0001 each with one voting right (and deferred shares of £0.0999 each with limited rights and which will not be admitted to trading). Admission in respect of such New Ordinary Shares will become effective and that dealings in those New Ordinary Shares will commence on 14 February 2024.

The above figure of 11,161,483 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The results of the poll were as follows:

	Resolutions	For	%	Against	%	Withheld
1	To receive and adopt the accounts for the financial year ended 30 June 2023.	3,374,840	99.19	27,718	0.81	4,837
2	To re-appoint RPG Chartered Accountants as Auditors.	3,369,888	99.17	28,070	0.83	9,437
3	To authorise the Directors to determine the remuneration of the Auditors.	3,369,670	99.03	32,888	0.97	4,837
4	To re-appoint Bradley Tyler Taylor as a Director.	3,205,262	94.20	197,226	5.80	4,907
5	To re-appoint Bela Lendvai-Lintner as a Director.	3,206,467	94.24	196,021	5.76	4,907
6	To re-appoint Victor Humberdot as a Director.	3,206,467	94.24	196,021	5.76	4,907
7	To authorise the Directors to allot shares up to a maximum aggregate nominal amount of £4,668,047.83.	3,193,245	94.06	201,631	5.94	12,519
	Special Resolutions:
8	To empower the Directors to generally allot relevant equity securities.	3,193,597	94.07	201,279	5.93	12,519
9	Issued ordinary share capital be sub-divided and converted into one New Ordinary Share of £0.0001 and one Deferred Share of £0.0999.	3,192,372	93.91	207,104	6.10	7,919
10	To authorise the Directors to make market purchases of own shares.	3,371,803	99.19	27,673	0.81	7,919

- Ends -

For more information, please contact:

Iconic Labs

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGGPUAAPUPCGPW

Iconic Labs (LSE:ICON)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024